Evidence map›Paper›PMID 42206208›Full record

ArticleKidney medicine2026

Recurrent Neuro-Renal Syndrome With Acute Kidney Injury From Anti-Pan-Neurofascin Antibody Resurgence: A Case Report.

David De Saint Gilles, Cédric Rafat, Jérôme Joël Devaux, Clémence Marois, Simon Leclerc, Tomoko Takano, Isabelle Brochériou, Nadine Elatram, François Husser, Laurent Mesnard and 2 more

Abstract readCase Reports
In one paragraph

Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

David De Saint GillesSoins Intensifs Néphrologiques et Rein Aigu (SINRA), Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.
Cédric RafatSoins Intensifs Néphrologiques et Rein Aigu (SINRA), Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.
Jérôme Joël DevauxInstitut de Génomique Fonctionnelle, Université de Montpellier, CNRS, INSERM, Montpellier, France.
Clémence MaroisSorbonne Université, Paris, France.
Simon LeclercDepartment of Medicine, Division of Clinical and Translational Research, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.
Tomoko TakanoDepartment of Medicine, Division of Clinical and Translational Research, Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.
Isabelle BrochériouSorbonne Université, Paris, France.
Nadine ElatramService d'Anatomie et Cytologie Pathologiques, Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.
François HusserSoins Intensifs Néphrologiques et Rein Aigu (SINRA), Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.
Laurent MesnardSoins Intensifs Néphrologiques et Rein Aigu (SINRA), Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.
David BuobService d'Anatomie et Cytologie Pathologiques, Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.
Cyril MousseauxSoins Intensifs Néphrologiques et Rein Aigu (SINRA), Assistance publique - Hôpitaux de Paris, Hôpital Tenon, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the case of a patient with a severe neuro-renal syndrome characterized by acute-onset autoimmune nodopathy and nephrotic syndrome with acute kidney injury. The presence of IgG3 antibodies anti-pan-neurofascin (Nfasc155/186) confirmed the autoimmune nature of this pathology and justified treatment with plasma exchange, corticosteroids, tacrolimus, and subsequently rituximab. Kidney biopsy revealed focal segmental glomerulosclerosis lesions. This therapeutic approach led to complete remission of the clinical presentation.

Indexed as

Acute kidney injuryneurofascinneuro-renal syndrome

Identifiers

PMID42206208
PMCPMC13202265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.